Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV
A case report of drug-induced rhabdomyolysis in a 34-year-old HIV-infected male with a history of liver disease and concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir is presented.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2003 |
---|---|
Erschienen: |
2003 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
AIDS patient care and STDs - 17(2003), 5 vom: 15. Mai, Seite 207-10 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mah Ming, Jinell B [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 11.08.2003 Date Revised 30.11.2018 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM125799497 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM125799497 | ||
003 | DE-627 | ||
005 | 20231222210510.0 | ||
007 | tu | ||
008 | 231222s2003 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0420.xml |
035 | |a (DE-627)NLM125799497 | ||
035 | |a (NLM)12816614 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mah Ming, Jinell B |e verfasserin |4 aut | |
245 | 1 | 0 | |a Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV |
264 | 1 | |c 2003 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 11.08.2003 | ||
500 | |a Date Revised 30.11.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A case report of drug-induced rhabdomyolysis in a 34-year-old HIV-infected male with a history of liver disease and concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir is presented | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a HIV Protease Inhibitors |2 NLM | |
650 | 7 | |a Heptanoic Acids |2 NLM | |
650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
650 | 7 | |a Pyrimidinones |2 NLM | |
650 | 7 | |a Pyrroles |2 NLM | |
650 | 7 | |a Lopinavir |2 NLM | |
650 | 7 | |a 2494G1JF75 |2 NLM | |
650 | 7 | |a Atorvastatin |2 NLM | |
650 | 7 | |a A0JWA85V8F |2 NLM | |
650 | 7 | |a Clarithromycin |2 NLM | |
650 | 7 | |a H1250JIK0A |2 NLM | |
650 | 7 | |a Ritonavir |2 NLM | |
650 | 7 | |a O3J8G9O825 |2 NLM | |
700 | 1 | |a Gill, M John |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t AIDS patient care and STDs |d 1996 |g 17(2003), 5 vom: 15. Mai, Seite 207-10 |w (DE-627)NLM09547725X |x 1557-7449 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2003 |g number:5 |g day:15 |g month:05 |g pages:207-10 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2003 |e 5 |b 15 |c 05 |h 207-10 |